Đang chuẩn bị liên kết để tải về tài liệu:
Diffuse parenchymal lung disease as first clinical manifestation of GATA-2 deficiency in childhood

Không đóng trình duyệt đến khi xuất hiện nút TẢI XUỐNG

GATA-2 transcription factor deficiency has recently been described in patients with a propensity towards myeloid malignancy associated with other highly variable phenotypic features: chronic leukocytopenias (dendritic cell-, monocyto-, granulocyto-, lymphocytopenia), increased susceptibility to infections, lymphatic vasculature abnormalities, and sensorineural deafness. |

TÀI LIỆU LIÊN QUAN

Diagnostic yield and risk/benefit analysis of trans-bronchial lung cryobiopsy in diffuse parenchymal lung diseases: A large cohort of 699 patients

Diffuse parenchymal pulmonary amyloidosis associated with multiple myeloma: A case report and systematic review of the literature

Diffuse parenchymal lung disease as first clinical manifestation of GATA-2 deficiency in childhood

Non-invasive mechanical ventilation in patients with diffuse interstitial lung diseases

Circulating concentration of markers of angiogenic activity in patients with sarcoidosis and idiopathic pulmonary fibrosis

Safe and effective use of nivolumab for treating lung adenocarcinoma associated with sporadic lymphangioleiomyomatosis: A rare case report

The benefits of exercise training in interstitial lung disease: Protocol for a multicentre randomised controlled trial

Diagnostic yield of transbronchial cryobiopsy in non-neoplastic lung disease: A retrospective case series

Trans-bronchial lung cryobiopsy in patients at high-risk of complications
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.